OverviewChartNewsTraderScreen

Goldman Sachs Knock-Out LLY/  DE000GG1MM99  /

EUWAX
2024-06-17  5:53:51 PM Chg.+0.40 Bid8:34:32 PM Ask8:34:32 PM Underlying Strike price Expiration date Option type
26.53EUR +1.53% 26.92
Bid Size: 10,000		 26.95
Ask Size: 10,000		 Eli Lilly and Co 599.9376 USD 2078-12-31 Call
GlobeNewswire 2:30 PM Atossa Set to Join Russell 3000® Index Effective June 28, 2024
GlobeNewswire 06-14 TScan Therapeutics Announces Updates to its Board of Directors
GlobeNewswire 06-11 Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D ...
TeleTrader 06-10 FDA advisors endorse Eli Lilly's Alzheimer's drug
GlobeNewswire 06-10 Sermonix Pharmaceuticals Announces Breast Cancer Research Publication of Paper Examining Lasofoxifen...
GlobeNewswire 06-06 Sermonix Pharmaceuticals Announces Chinese Approval of Investigational New Drug Application for Laso...
TeleTrader 06-05 Alphabet appoints Anat Ashkenazi as new CFO
GlobeNewswire 06-03 HUTCHMED Highlights Publication of Phase III FRUTIGA Results in Nature Medicine
GlobeNewswire 05-30 Sermonix Pharmaceuticals to Present Poster on ELAINE-3 Trial in Progress at ASCO 2024
GlobeNewswire 05-30 Anaqua Annual User Experience Conference to Feature Keynotes from Microsoft, SAP, USPTO, and More
GlobeNewswire 05-24 Gov. Holcomb Joins Lilly to Announce Additional $5.3 Billion Investment at LEAP District
TeleTrader 05-24 Eli Lilly to reveal $5.3B production boost
TeleTrader 05-21 Eli Lilly's diabetes drug receives authorization in China
GlobeNewswire 05-16 BeyondSpring R&D Day Highlights New Plinabulin Development Strategy for Cancer and Updates for SEED ...
GlobeNewswire 05-16 Totus Medicines Announces Strategic Multi-Target Research Collaboration with Lilly
GlobeNewswire 05-13 Atossa Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 05-13 Lycia Therapeutics Completes $106.6 Million Series C Financing to Advance Pipeline of LYTAC Extracel...
GlobeNewswire 05-09 ProQR Announces First Quarter 2024 Operating and Financial Results
GlobeNewswire 05-08 Merus Announces Financial Results for the First Quarter 2024 and Provides Business Update
GlobeNewswire 05-08 Erasca Reports First Quarter 2024 Business Updates and Financial Results
GlobeNewswire 05-08 Therini Bio Announces Positive Preclinical Data Supporting the Development of THN391 in Neurodegener...
GlobeNewswire 05-08 IMUNON Appoints Director Dr. Stacy R. Lindborg as President and CEO
GlobeNewswire 05-01 H1 Appoints Seasoned Marketing & Technology Executive Karen Walker to Its Board of Directors
GlobeNewswire 04-30 ViaNautis Bio appoints Dr Steven M. Altschuler as Chairman of its Board of Directors
TeleTrader 04-30 Eli Lilly's Q1 revenue surges 26% to $8.8B